Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with or without PD-L1 selection: A systematic review and network meta-analysis

Li, Y; Liang, XY; Li, HJ; Chen, XY

Chen, XY (通讯作者)，Guangxi Acad Med Sci, Dept Pharm, 6 Taoyuan Rd, Nanning 530021, Guangxi, Peoples R China.;Chen, XY (通讯作者)，Guangxi Acad Med Sci, Phase Clin Trial Lab 1, 6 Taoyuan Rd, Nanning 530021, Guangxi, Peoples R China.;Chen, XY (通讯作者)，Peoples Hosp Guangxi Zhuang Autonomous Reg, 6 Taoyuan Rd, Nanning 530021, Guangxi, Peoples R China.

CHINESE MEDICAL JOURNAL, 2023; 136 (18): 2156

Abstract

Background: Immune checkpoint inhibitors (ICIs) are standard treatments for advanced non-small cell lung cancer (NSCLC); however, evidence regarding t......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索